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A B S T R A C T   
We report a case of a 56-year-old Brazilian woman, with relapsing lepromatous leprosy, and onychomycosis 
caused by a non-dermatophyte filamentous fungi. The pathogenic fungi was identified as Arthrinium arundinis 
and treated with chemical abrasion of the nail with 40% urea and application of terbinafine cream. Onycho-
mycosis caused by Arthrinium species is rare, and this is the second reported case.   
1. Introduction 
Onychomycosis are fungal infections of the nail plate. Commonly 
caused by dermatophytes, but also by yeasts and non-dermatophyte 
filamentous fungi (NDFF) [1]. Most NDFF do not have keratinophilic 
activity, it is a secondary invader of previously traumatized or damaged 
nails [2]. 
The NDFF most often described causing onychomycosis are Scopu-
lariopsis brevicaulis, Fusarium sp., Acremonium sp., Aspergillus sp., Sci-
tallidium sp., and Scedosporium sp [3–5]. This species are usually 
resistant to conventional onychomycosis treatments [2,4,6]. The genus 
Arthrinium comprises a group of NDFF, most of the species are endo-
phytes of several plants [7]. Only one case of onychomycosis has been 
identified as caused by Arthrinium arundinis species [7]. The aim of this 
case is to report onychomycosis caused by Arthrinium arundinis in a 
lepromatous leprosy patient in Porto Alegre, Rio Grande do Sul, Brazil. 
2. Case presentation 
A 56 years-old female patient with relapsing lepromatous leprosy in 
polychemotherapy, bilateral cataract, visual deficit, hypertension, 
lupus, diabetes mellitus, osteoporosis, scleroderma, and renal failure in 
first readministration of multidrug therapy (day 0). The patient was 
attended in the Ambulatório de Dermatologia Sanitária (ADS) in Porto 
Alegre. The leprosy treatment follows the multidrug therapy (MDT) 
protocol recommended by the World Health Organization (WHO) [8]. 
Rifampicin, dapsone and clofazimine are standard MDT drugs. As this 
patient developed dapsone-induced anemia, our medical team decided 
to use rifampicin, ofloxacin and clofazimine, an alternative MDT rec-
ommended by WHO. Peripheral neuropathy and immunological re-
actions are common in leprosy patients. In this case, the patient 
presented leprous nodular erythema and chronic neuropathic pain. 
Thalidomide and amitriptyline were associated with MDT to treat these 
clinical conditions. A mycological exam was performed after clinical 
observation of total toenails dystrophy in the left foot, suggesting ony-
chomycosis (Fig. 1A). Direct examination of the nail scrapings showed 
hyaline septate hyphae, and branching at acute angles of <90◦ (Fig. 1D). 
The treatment was started immediately with chemical abrasion with a 
40% urea solution on the nail plate. On day 14, white and flat colonies 
were observed on Mycosel® agar (Fig. 1B) after incubation in 25 ◦C and 
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no growth was observed at 37 ◦C. A subculture on potato dextrose agar 
was performed from the initial colony and incubated at 25 ◦C. On day 
21, pale-brown single-celled conidia with a clear brightly opalescent 
equatorial ring were observed under the microscope. Conidia were 
sympodially generated and large cluster-aggregated conidiogenous cells 
suggesting Arthrinium sp. (Fig. 1C). A second and a third collection of 
nail material was performed on day 30 and day 60, cultured on Sabo-
uraud dextrose agar for seven days at 25 ◦C. The results confirmed the 
genus as the cause of the onychomycosis. For species identification of 
the first culture, the sequencing of Internal Transcribed Spacer (ITS) of 
rDNA using primers ITS 5 and 4 and part of the Translation Elongation 
Factor 1-alpha (TEF1-α) gene using primers EF1-728F and EF-2 were 
performed and compared against the GenBank database using the 
BLAST algorithm (www.ncbi.nlm.nih.gov/blast). These sequences 
showed 99.47% identity and 100% of coverage with strain Arthrinium 
arundinis CBS 106.12 (access number being MK539828 and MT622850). 
Eleven clinical antifungals (Sigma-Aldrich, USA) were evaluating ac-
cording to the protocol M38-A2 of the Clinical and Laboratory Standards 
Institute (CLSI), using the microdilution technique and the inoculum 
was standardized to 2 × 104 CFU/mL in test [9]. 
The caspofungin minimal effective concentration (MEC) was evalu-
ated, and for the other antifungals, the minimal inhibitory concentra-
tions (MICs) was considered when no grow was visually observed. 
Excepting terbinafine, amphotericin B and posaconazole, the isolate had 
higher MICs and MEC for all other antifungals tested (Table 1). We 
decided for a conservative treatment with chemical abrasion, instructing 
the patient to gently sand the altered areas of the nails, and apply a 40% 
urea solution on the nail plate, once a week, associated with the dayly 
use of terbinafine 1% cream. The patient is still in follow-up and 
reviewed monthly showing slight improvements in 3 months of 
treatment. 
3. Discussion 
Onychomycosis is the most common nail disease and has a preva-
lence of 5.5% in the world population [1]. Around 60%–70% of these 
infections can be caused by dermatophyte fungi. Yeasts are responsible 
for 10%–20% of cases, and the NDFF represent 10%–20% of fungal nail 
infections [1,4]. Some NDFF can cause nail infections directly, others 
can secondarily infect nails with minor trauma, but often these fungi are 
only local contaminants [2]. 
The genus Arthrinium (family Apiosporaceae) comprises a group of 
NDFF, geographically widely distributed, commonly saprobes, but also 
parasites of a large number of plant species [10,11]. Until now, 70 
species of Arthrinium fungi have been reported and they are, generally, 
Fig. 1. Onychomycosis caused by Arthrinium aurundinis in leprosy patient (A); Arthrinium arundinis colony in Sabouraud agar plate after 7 days (B); Microcultive in 
potato dextrose agar at 25 ◦C after 7 days, 400x (C); Direct mycological examination, 400x(D). 
Table 1 
Antifungal susceptibility testing results of Arthrinium arundinis isolated from the 
nail scrapings in a leprosy patient.  
Antifungal Minimal Inhibitory Concentrations (MICs) and Minimal 
Effective Concentration (MEC)a (μg/mL) 
Terbinafine 0.0312 
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not implicated in human or animal disease [11]. However, two skin 
infection cases in humans caused by Arthrinium phaeospermum [12,13] 
and one case of onychomycosis caused by A. aurundinis have already 
been described [7]. 
Pardo-Castello and Pardo [14]observed the presence of onychomy-
cosis in 20%–30% of leprosy patients. Leprosy patients tend to have nail 
changes and onychomycosis more frequently than the general popula-
tion, mainly due to the frequent trauma resulting from peripheral neural 
impairment caused by Mycobacterium leprae during its infectious process 
[15], which may favor the infection of NDFF. 
The laboratory diagnosis of NDFF onychomycosis is not simple, and 
there is no standard criterion for the diagnosis. In the present case, to 
reduce the chances of NDFF being a contaminant, the following criteria 
were used: the identification of irregular hyphae in the direct myco-
logical examination of the nail scraping of three consecutive collections 
with intervals of one month between each one; obtaining three positive 
cultures on Sabouraud dextrose agar in the three different collections; 
and the failure to obtain dermatophyte fungi isolation in cultures of the 
same nail material on Mycosel® agar [2,4]. For species identification, it 
was performed the sequencing of ITS and TEF1-α fungus genes [7,16]. 
There is no standard treatment protocol described for NDFF ony-
chomycosis. Gupta et al. [4] described efficient treatments using oral 
terbinafine or itraconazole for Scopulariopsis brevicaulis and Aspergillus 
species. The efficacy in the topical use of terbinafine, after chemical 
avulsion, is described in 2 cases of onychomycosis caused by Acre-
monium species [4]. Pulsed terbinafine promoted complete cure in 30 of 
34 cases of Aspergillus onychomycosis according to Gupta et al. [4]. 
Regarding Scopulariopsis species, 24 out of 32 cases were successfully 
treated with pulsed itraconazole, where 12 out of 14 cases improved 
with daily use of terbinafine 250 mg. 
Tosti et al. [17], reported 59 cases of NDFF onychomycosis. The 
authors obtained better results when using topical treatments compared 
to systemic treatments. Sixteen patients with onychomycosis caused by 
S. brevicaulis were treated with ciclopirox 8% nail lacquer or topical 
terbinafine (for 8–12 months) after nail avulsion, and 11 patients were 
successful healed. 
The first reported case of A. arundinis as causing onychomycosis was 
resistant to fluconazole and caspofungin, and susceptible to itracona-
zole, voriconazole and posaconazole [7]. However, in the present case, 
the isolate was susceptible to amphotericin B and was not susceptible to 
itraconazole, results contrary to those obtained by the first published 
case report. Thus, evaluations of superficial mycoses, identification and 
antifungal susceptibility testing are important to guide management 
[1–5]. 
The first reported case of onychomycosis caused by A. arundinis was 
successfully carried out in the treatment with pulsed itraconazole [7]. 
However, in our case, the isolated fungus from the leprosy patient 
showed a MIC higher than 16 μg/mL, which classifies our isolate as 
resistant to this drug. The low terbinafine MIC obtained in vitro sug-
gested the use of this drug for the onychomycosis treatment. The oral 
terbinafine administration in this patient was not adequate due the 
presented comorbidities. The use of this drug systemically could worsen 
anemia and visual impairment, in addition to the possible drug inter-
action with the medication administered to the patient for the treatment 
of her comorbidities. Due to the reported factors, we chose a 
conservative topical terbinafine treatment twice a day, and monthly 
clinical follow-up. We plan to maintain exclusively topical treatment 
until the end of leprosy treatment in approximately 6 months, if no 
improvement is obtained, we will start a monitored oral terbinafine 
treatment. 
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